Extending the Limits of Protection of Pharmaceutical Patents and Data Outside the EU - Is There a Need to Rebalance?




Daniel Acquah

PublisherSpringer Max Planck Institute for Innovation and Competition

Berlin Heidelberg

2014

IIC - International Review of Intellectual Property and Competition Law

IIC

45

3

256

286

31

2195-0237

DOIhttps://doi.org/10.1007/s40319-014-0183-1




Last updated on 2024-26-11 at 18:12